Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-935P is a **pseudogene** sequence of the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a key non-coding RNA involved in pre-mRNA splicing as a component of the spliceosome[1][3], but RNU6-935P itself, being annotated as a pseudogene, is not transcribed into a functional RNA or protein. Pseudogenes such as RNU6-935P may arise from retrotransposition events (often mediated by LINE elements) that create non-functional duplicates of snRNA genes in the genome[2]. These copies generally do not have a biological function, are not involved in disease pathways, and are not considered drug targets or biomarkers. They serve primarily as indicators of genome evolution and retrotransposition activity[2][5]. **Clarifications and essential context:** - **Pseudogene status**: RNU6-935P is a processed pseudogene related to the U6 snRNA. Pseudogenes are generally *non-functional genetic elements*; they **do not encode active biomolecules**, and thus are not valid therapeutic targets, receptors, enzymes, or biomarkers[2][5]. - **U6 snRNA** itself (the functional gene, not the pseudogene) is a non-coding RNA central to the splicing of pre-mRNA in the spliceosome, highly conserved and essential for splicing activity[1][3]. Numerous U6-derived pseudogenes exist throughout vertebrate genomes[1][2]. - **No known role in disease or drug action:** There is no evidence that RNU6-935P participates in pathophysiology, interacts with drugs, or serves any diagnostic or monitoring function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 935, pseudogene (RNU6-935P).